In addition, our study shows that the IR can support proliferation in NSCLC cell lines subject to IGF1R inhibition, and suggest that it is the ratio of IR:IGF1R expression that defines the sensitivity to inhibition of the IGF1R and indeed whether any benefit may be achieved from additionally targeting the IR. This evidence concerns the gene IGF1R and non-small cell lung carcinoma.